Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SRDX | Common Stock | Sale | -$135K | -2.5K | -5.18% | $53.80 | 45.8K | May 20, 2021 | Direct | F1, F2, F3 |
transaction | SRDX | Common Stock | Gift | $0 | -1K | -2.18% | $0.00 | 44.8K | May 20, 2021 | Direct |
Id | Content |
---|---|
F1 | Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021 |
F2 | Reflects the weighted average price of 2,500 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on May 20, 2021 with sale prices ranging from $53.42 to $54.265 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F3 | Includes 214 shares acquired through the Employee Stock Purchase Plan for the phase ending February 26, 2021. |